Catalyst Biosciences' Series B Round

Catalyst Biosciences raised a round of funding on February 15, 2006.

Catalyst Biosciences is developing next generation biopharmaceuticals by harnessing the catalytic power of engineered proteases that target proteins underlying diseases. Catalyst's discovery platform …

Articles about Catalyst Biosciences' Series B Round: